PDF

Download the 2018 Agenda

Download the 2018 Agenda

Download the agenda for more information on the topic sessions that will be discussed at the Pharmaceutical Packaging and Labeling Conference, taking place in Zurich, Switzerland on the 18th - 20th June 2018.
Improving Patient Compliance via Packaging and Labelling

Improving Patient Compliance via Packaging and Labelling

Patients rely on the information provided on a product to instruct them in a manner which will lead to safe and effective use. Therefore any flout in accuracy could have fatal consequences. In this top tips eBooK on improving patient compliance via packaging and labelling, we spoke with packaging specialist Karel van der Waarde about the the strategies used to enhance compliance with patients to help them follow the therapy plan more effectively.
International EU Compliance eHandbook Pharmaceutical Labelling

International EU Compliance eHandbook Pharmaceutical Labelling

In response to the challenges faced in tracking and meeting the country specific labeling requirements of EU member states, Pharma IQ has produced this e-handbook based on a recent EU guideline.
Sample Delegate List

Sample Delegate List

Take a look at last year's attendee list
Tamper Evidence in Pharma Packaging - Expert Insight eBook

Tamper Evidence in Pharma Packaging - Expert Insight eBook

The anti-counterfeit packaging market is forecasted to reach US$206.57 billion by 2021, just shy of doubling its 2016 figure of $107.26 bn. This growth is supported by the expanding pharma and food and beverage industries, with Asia Pacific set to take the largest market share. China is earmarked to lead the way in 2021 with its drive in manufacturing activities fueling that lead.

The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. In this ebook we look at the road to meeting the 2019 FMD deadline, finding the most suitable anti tamper evidence feature as well as patient compliance and future trends in the industry.

Insight from:

Dieter Mößner
Edelmann GmbH/ Convenor of ISO TC 122 WG 15 “Tamper Verification Features on medicinal product packaging

Horst Kastrup
Senior RegulatoryAdvisor
MEDA Pharma

Download the 2018 Programme

Download the 2018 Programme

Download the Packaging and Labelling Summit 2018 Agenda for a full list of speakers and sessions.
The Cost of Compliance in the Regulatory Landscape of the FMD

The Cost of Compliance in the Regulatory Landscape of the FMD

Ahead of the Pharmaceutical Packaging and Labelling Summit 2018, we have put together this article on the costs and challenges of compliance in the complex regulatory landscape of the FMD, including the financial implications, maintaining cost- efficiency and the future of the regulatory landscape.

Will the smart packaging revolution transform therapy adherence?

Will the smart packaging revolution transform therapy adherence?

Key opportunities for smart packaging within pharmaceuticals include the promotion of therapy adherence, more organised and efficient data collection and the growth of personalised medicines. However, there are several obstacles which may hinder the widespread implementation of smart technologies, the most prevalent of which is bringing these projects to scale in an affordable manner. 

This article discusses the realities of smart packaging implementation, the tangible benefits it can bring to both pharma and patients, and the direction in which the industry is likely to develop over the coming years. 

Industry Guide: Tracking & Packing for Pharmaceuticals

Industry Guide: Tracking & Packing for Pharmaceuticals

We have put together the very best content pieces from 2018 into one handy industry guide. This guide includes: Serialisation Track and Trace Map, Tackling Tampering in Pharma Packaging, Smart Packaging Solutions and much more!

Build Or Buy?

Build Or Buy?

Having a dedicated Artwork Management System for managing packaging and labelling for your organization is essential. However, many companies attempt to build a system internally, using a variety of tools that interface poorly with each other, adding challenges over a paper based system. Perigord’s Global Quality Director, Suzanne Ivory lays out the pros and cons of building or buying an AMS and offers recommendations to companies considering adopting one, including validation issues, platform security and more.

Tackling tampering in pharma packaging

Tackling tampering in pharma packaging

Pharmaceutical companies need to define, specify, test and choose the tamper verification feature for their existing and future packaging portfolio. This article will explore the weak points in anti tampering packaging in relation to pharmaceutical products and how these areas can be addressed. 

How To Manage Your Packaging And Labelling Partners

How To Manage Your Packaging And Labelling Partners

To ensure packaging and labelling streams are compliant and implemented both swiftly and cost effectively each stakeholder must perform their task in the correct sequence, using the right information and tools. With this in mind, Pharma IQ examines some of the latest tech and trends utilised in the process of managing packaging and labelling partners within pharma.
Pharmaceutical Packaging and Labeling 2016 Trend Report

Pharmaceutical Packaging and Labeling 2016 Trend Report

In this research report, Pharma IQ explores the trends, both prominent and emerging, within the pharmaceutical packaging and labeling 2016 market. Also, Suzanne Ivory, Head of Quality at Perigord provides insight into overcoming artwork obstacles on the route to market.